Abstract #3922

Applying 2HG MRS in glioma patients during routine clinical MRI examination

Zahra Shams¹, Sarah M. Jacobs¹, Jan W. Dankbaar¹, Changho Choi², Dennis W.J. Klomp¹, Jannie P. Wijnen¹, and Evita C. Wiegers¹

¹Department of Radiology, University Medical Center Utrecht, Utrecht, Netherlands, ²Advanced Imaging Research Center, University of Texas Southwestern Medical Center, Dallas, TX, United States

2HG is a valuable biomarker to detect mutational status of glioma patients. Therefore, it is of great value to be widely integrated into clinical practice. This study investigates the performance of along echo time (PRESS 97ms) ¹H MRS protocol at 3Tesla to be used in routine clinical glioma imaging.

This abstract and the presentation materials are available to members only; a login is required.

Join Here